The CanISleepinMS Study: Effect of Cannabidiol (CBD) on Sleep Quality in Patients With Multiple Sclerosis

Study acronym: CanISleepinMS
StatusCompleted
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Evaluating the effect of 300 mg purified cannabidiol (CBD) on sleep quality in patients with multiple sclerosis (MS).
Trial Details
NCT Number NCT07840924
Lead Sponsor Wageningen University
Collaborators: Nationaal MS Fonds, Rijnstate Hospital, Sleep Medicine Centre Kempenhaeghe
Conditions
(from sponsor)		 Sleep Quality, Multiple Sclerosis, Insomnia
Related terms Multiple Sclerosis, Sleep Initiation and Maintenance Disorders
Enrollment 16 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov